Endocrinopathies in transfusion-associated iron overload

Clinical Endocrinology

Volumn 78, Issue 2, 2013, Pages 271-277

  Kim, Mee Kyoung ^a   Lee, Jong Wook ^a   Baek, Ki Hyun ^a   Song, Ki Ho ^a   Kwon, Hyuk Sang ^a   Oh, Ki Won ^b   Jang, Eun Hee ^a   Kang, Moo Il ^a   Lee, Kwang Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICORELIN TRIFLUOROACETATE; CORTICOTROPIN RELEASING FACTOR; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GONADORELIN; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; SOMATORELIN ACETATE; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BONE DENSITOMETRY; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOCHROMATOSIS; HIP; HORMONAL REGULATION; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS FUNCTION; HYPOPHYSIS GONAD SYSTEM; IRON OVERLOAD; LUMBAR SPINE; MALE; ORAL GLUCOSE TOLERANCE TEST; OSTEOPOROSIS; PITUITARY HORMONAL DEFICIENCY; PRIORITY JOURNAL; SCORING SYSTEM; SEX RATIO; TRABECULAR BONE; TRANSFUSION ASSOCIATED IRON OVERLOAD;

ADULT; BLOOD GLUCOSE; BLOOD TRANSFUSION; FEMALE; HOMEOSTASIS; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; OSTEOPOROSIS; PITUITARY DISEASES; YOUNG ADULT;

EID: 84872120561     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04495.x     Document Type: Article

References (28)

1. Hollán, S.R., (1997) Transfusion-associated iron overload. Current Opinion in Hematology, 4, 436-441.
2. Jacobs, A., (1997) Iron overload-clinical and pathologic aspects. Seminars in Hematology, 14, 89-113.
3. Schafer, A.I., Cheron, R.G., Dluhy, R., et al,. (1981) Clinical consequences of acquired transfusional iron overload in adults. New England Journal of Medicine, 304, 319-324.
4. Walsh, C.H., (2000) Non-diabetic endocrinopathy in hemochromatosis. In:, J.C. Barton, C.Q. Edwards, eds. Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University Press, Cambridge, 278-289.
5. Gardenghi, S., Grady, R.W., &, Rivella, S., (2010) Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia. Hematology/oncology Clinics of North America, 24, 1089-1107.
6. Lee, J.W., Yoon, S.S., Shen, Z.X., et al,. (2010) Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. Blood, 116, 2448-2454.
7. Lee, J.W., (2008) Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea. International Journal of Hematology, 88, 16-23.
8. Swinkels, D.W., Jorna, A.T., &, Raymakers, R.A., (2007) Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis. Netherlands Journal of Medicine, 65, 452-455.
9. Shlomo Melmed, J., &, Jameson, J.L., (2008) Disorders of the anterior pituitary and hypothalamus. In:, A.S. Fauci, E. Braunwald, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L. Jameson, J. Loscalzo,. Harrison's principles of internal medicine. McGraw-Hill, New York, 2195-2216.
10. Giri, N., Batista, D.L., Alter, B.P., et al,. (2007) Endocrine abnormalities in patients with Fanconi anemia. Journal of Clinical Endocrinology & Metabolism, 92, 2624-2631.
11. Lamberts, S.W., de Herder, W.W., &, van der Lely, A.J., (1998) Pituitary insufficiency. Lancet, 352, 127-134.
12. American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care, 35 (Suppl 1), S64-S71.
13. Kanis, J.A., Melton III, L.J., Christiansen, C., et al,. (1994) The diagnosis of osteoporosis. Journal of Bone and Miner Research, 9, 1137-1141.
14. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
15. Walton, C., Kelly, W.F., Laing, I., et al,. (1983) Endocrine abnormalities in idiopathic haemochromatosis. Quarterly Journal of Medicine, 52, 99-110.
16. Stocks, A.E., &, Martin, F.I., (1968) Pituitary function in haemochromatosis. American Journal of Medicine, 45, 839-845.
17. McClain, D.A., Abraham, D., Rogers, J., et al,. (2006) High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia, 49, 1661-1669.
18. Merkel, P.A., Simonson, D.C., Amiel, S.A., et al,. (1988) Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. New England Journal of Medicine, 318, 809-814.
19. Tuomainen, T.P., Nyyssönen, K., Salonen, R., et al,. (1997) Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care, 20, 426-428.
20. Kim, M.K., Baek, K.H., Song, K.H., et al,. (2012) Increased serum ferritin predicts the development of hypertension among middle-aged men. American Journal of Hypertension, 25, 492-497.
21. Angelopoulos, N.G., Goula, A.K., Papanikolaou, G., et al,. (2006) Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporosis International, 17, 150-155.
22. Guggenbuhl, P., Deugnier, Y., Boisdet, J.F., et al,. (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporosis International, 16, 1809-1814.
23. Tanimoto, K., Okubo, Y., Harada, C., et al,. (2008) Latent hypoparathyroidism in an osteoporotic patient with multiple endocrinopathies and secondary hemochromatosis due to multiple blood transfusions, unmasked by alendronate and glucocorticoid at adrenal crisis. Internal Medicine, 47, 515-520.
24. Gertner, J.M., Broadus, A.E., Anast, C.S., et al,. (1979) Impaired parathyroid response to induced hypocalcemia in thalassemia major. The Journal of Pediatrics, 95, 210-213.
25. Shirota, T., Shinoda, T., Aizawa, T., et al,. (1992) Primary hypothyroidism and multiple endocrine failure in association with hemochromatosis in a long-term hemodialysis patient. Clinical Nephrology, 38, 105-109.
26. McDermott, J.H., &, Walsh, C.H., (2005) Hypogonadism in hereditary hemochromatosis. Clinics in Endocrinology and Metabolism, 90, 2451-2455.
27. Utzschneider, K.M., &, Kowdley, K.V., (2010) Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nature Reviews. Endocrinology, 6, 26-33.
28. O' Sullivan, E.P., McDermott, J.H., Murphy, M.S., et al,. (2008) Declining prevalence of diabetes mellitus in hereditary haemochromatosis-the result of earlier diagnosis. Diabetes Research and Clinical Practice, 81, 316-320.